Dyne therapeutics competitors
WebDyne Therapeutics Inc Working Capital Per Revenue on the trailing twelve month basis from the forth quarter 2024 to forth quarter 2024, Trends and Ranking, Fundamental Ratios - CSIMarket ... Dyne Therapeutics Inc 's Competition Performance; Dyne Therapeutics Inc 's Competitors Results; DYN's Competitors Stock Performance; WebApr 9, 2024 · Dyne Therapeutics, Inc. Competitors. Emergent BioSolutions. NYSE:EBS US$529.5m. 4D Molecular Therapeutics. NasdaqGS:FDMT US$535.7m. Alector. NasdaqGS:ALEC US$518.1m. ARS Pharmaceuticals. NasdaqGM:SPRY US$549.4m. Price History & Performance. ... Dyne Therapeutics, Inc., a muscle disease company, …
Dyne therapeutics competitors
Did you know?
WebNov 3, 2024 · Cash position: Cash, cash equivalents and marketable securities were $248.1 million as of September 30, 2024, which is anticipated to fund operations through 2024. Research and development (R&D) expenses: R&D expenses were $34.7 million for the quarter ended September 30, 2024, compared to $36.5 million for the quarter ended … WebDec 30, 2024 · Peers & Competitors. Follow $11.59 0.19 (+1.67%) 3:59 PM 12/30/22. ... Dyne Therapeutics, Inc. (DYN) key stats comparison: compare with other stocks by …
WebAug 1, 2024 · Dyne Therapeutics: ClinicalTrials.gov Identifier: NCT05481879 Other Study ID Numbers: DYNE101-DM1-201 2024-000889-18 ( EudraCT Number ) First Posted: August 1, 2024 Key Record Dates: Last Update Posted: April 7, 2024 Last Verified: April 2024 Individual Participant Data (IPD) Sharing Statement: ... WebFind Dyne Therapeutics stock competitors. Compare other stocks that are similar to DYN in performance, different metrics, and ratios. ... Dyne Therapeutics (DYN) Similar …
WebThe Competitors page allows you to view information for other symbols found in the same sector. In the table, you'll find all the components (individual stock symbols) found in that … WebSep 6, 2024 · Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases. With its proprietary FORCE™ platform, Dyne is developing modern oligonucleotide therapeutics that are designed to overcome limitations in delivery to …
WebModerna Inc. stock outperforms competitors on strong trading day. MRNA +3.87% COMP +1.97%. MarketWatch · 2 days ago. Analyst. ... Dyne Therapeutics Inc. is a muscle disease company. The Company ...
WebDyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven … how to see cell numbers on notionWebFeb 9, 2024 · Competitors: Unknown. Dyne Therapeutics Reviews ... Glassdoor gives you an inside look at what it's like to work at Dyne Therapeutics, including salaries, … how to see cell in excelWebNov 3, 2024 · A cash runway is defined as the length of time it would take a company to run out of money if it kept spending at its current rate of cash burn. In June 2024, Dyne … how to see cd key steam 2021WebDyne Therapeutics to Present at Chardan’s 6th Annual Genetic Medicines Conference WALTHAM, Mass., Sept. 27, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. … how to see cash app account numberWebDyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases. With its proprietary ... how to see cathedral rock in sedonahow to see cell phone screen in sunlightWebApr 3, 2024 · “ Dyne’s breakthrough approach brings the power of modern oligo therapeutics and other payloads to patients with serious muscle diseases," said Jason Rhodes, a partner at Atlas Venture and ... how to see cell formula in excel